Tesamorelin and Visceral Adipose Tissue: GHRH-Analog Research Mechanisms

For laboratory and qualified research professional use only.

Tesamorelin, a growth-hormone-releasing hormone (GHRH) analogue, is frequently studied in visceral adipose tissue research. This article outlines the key laboratory mechanisms under investigation.

GHRH Receptor Activation

In pituitary and adipocyte models, tesamorelin stimulates the GHRH receptor, leading to increased growth-hormone release and downstream effects on lipid metabolism.

Adipose Tissue Reduction Models

Laboratory studies using human visceral fat explants and 3T3-L1 cells have documented tesamorelin’s ability to modulate lipolysis and reduce fat accumulation under controlled conditions.

Comparative GH Studies

Researchers regularly compare tesamorelin with other GH secretagogues to understand differences in receptor specificity and metabolic outcomes in in-vitro systems.

For laboratory and qualified research professional use only.

→ Tesamorelin Research-Grade Peptide
→ Weight Loss Research Peptides
→ Tesamorelin Mechanism of Action